Germline BRCA1-2 Mutations in Non-Ashkenazi Families with Double Primary Breast and Ovarian Cancer

By Schorge J.O.   Mahoney N.M.   Miller D.S.   Coleman R.L.   Muller C.Y.   Euhus D.M.   Tomlinson G.E.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 383-387

Elsevier

Access to resources Recommend Favorite

Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics

By Zuradelli Monica  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 251-258

Springer Publishing Company

Access to resources Recommend Favorite

p53 Inactivation is a Rare Event in Familial Breast Tumors Negative for BRCA1 and BRCA2 Mutations

By Sensi Elisa   Tancredi Mariella   Aretini Paolo   Cipollini Giovanna   Naccarato A. Giuseppe   Viacava Paolo   Bevilacqua Generoso   Caligo Maria A.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 1, 2003-01 ,pp. : 1-9

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

By Bayraktar Soley  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 145-153

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 Mutations in Patients with Familial Risk of Breast Cancer

By Garcia-Patiño Elena   Gomendio Blanca   Silva Jose M.   Garcia Jose M.   Provencio Mariano   España Pilar   Bonilla Felix  

Acta Oncologica, Vol. 37, Iss. 3, 1998-07 ,pp. : 299-300

Informa Healthcare

Access to resources Recommend Favorite